TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
|
| Series: | South Asian Journal of Cancer |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1801347 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841555861219049472 |
|---|---|
| author | Ritam Joarder Dhwani Patel Atul Tiwari Jatin Choudhary Pranaya Vana Vallish Shenoy Neha Mer Anant Ramaswamy Prabhat Bhargava Vikas Ostwal |
| author_facet | Ritam Joarder Dhwani Patel Atul Tiwari Jatin Choudhary Pranaya Vana Vallish Shenoy Neha Mer Anant Ramaswamy Prabhat Bhargava Vikas Ostwal |
| author_sort | Ritam Joarder |
| collection | DOAJ |
| format | Article |
| id | doaj-art-ca0acd3791344e4b970ce43cbbdb549d |
| institution | Kabale University |
| issn | 2278-330X 2278-4306 |
| language | English |
| publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
| record_format | Article |
| series | South Asian Journal of Cancer |
| spelling | doaj-art-ca0acd3791344e4b970ce43cbbdb549d2025-01-08T00:11:12ZengThieme Medical and Scientific Publishers Pvt. Ltd.South Asian Journal of Cancer2278-330X2278-430610.1055/s-0044-1801347TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective AnalysisRitam Joarder0Dhwani Patel1Atul Tiwari2Jatin Choudhary3Pranaya Vana4Vallish Shenoy5https://orcid.org/0000-0002-7076-4802Neha Mer6Anant Ramaswamy7Prabhat Bhargava8https://orcid.org/0000-0002-6440-2186Vikas Ostwal9https://orcid.org/0000-0002-0067-4748Department of Medical Oncology, Tata Memorial Hospital, HBNI, Dr. E Borges Road, Parel, Mumbai, IndiaDepartment of Medical Oncology, Tata Memorial Hospital, HBNI, Dr. E Borges Road, Parel, Mumbai, IndiaDepartment of Medical Oncology, Tata Memorial Hospital, HBNI, Dr. E Borges Road, Parel, Mumbai, IndiaDepartment of Medical Oncology, Tata Memorial Hospital, HBNI, Dr. E Borges Road, Parel, Mumbai, IndiaDepartment of Medical Oncology, Tata Memorial Hospital, HBNI, Dr. E Borges Road, Parel, Mumbai, IndiaDepartment of Medical Oncology, Tata Memorial Hospital, HBNI, Dr. E Borges Road, Parel, Mumbai, IndiaDepartment of Medical Oncology, Tata Memorial Hospital, HBNI, Dr. E Borges Road, Parel, Mumbai, IndiaDepartment of Medical Oncology, Tata Memorial Hospital, HBNI, Dr. E Borges Road, Parel, Mumbai, IndiaDepartment of Medical Oncology, Tata Memorial Hospital, HBNI, Dr. E Borges Road, Parel, Mumbai, IndiaDepartment of Medical Oncology, Tata Memorial Hospital, HBNI, Dr. E Borges Road, Parel, Mumbai, Indiahttp://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1801347bevacizumabchemotherapy-refractory colorectal cancerTAS-102tipiraciltrifluridine |
| spellingShingle | Ritam Joarder Dhwani Patel Atul Tiwari Jatin Choudhary Pranaya Vana Vallish Shenoy Neha Mer Anant Ramaswamy Prabhat Bhargava Vikas Ostwal TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis South Asian Journal of Cancer bevacizumab chemotherapy-refractory colorectal cancer TAS-102 tipiracil trifluridine |
| title | TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis |
| title_full | TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis |
| title_fullStr | TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis |
| title_full_unstemmed | TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis |
| title_short | TAS-102 Plus Bevacizumab as an Effective and Well Tolerated Regimen in Chemotherapy-Refractory Advanced Colorectal Cancers – A Single Institution Retrospective Analysis |
| title_sort | tas 102 plus bevacizumab as an effective and well tolerated regimen in chemotherapy refractory advanced colorectal cancers a single institution retrospective analysis |
| topic | bevacizumab chemotherapy-refractory colorectal cancer TAS-102 tipiracil trifluridine |
| url | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1801347 |
| work_keys_str_mv | AT ritamjoarder tas102plusbevacizumabasaneffectiveandwelltoleratedregimeninchemotherapyrefractoryadvancedcolorectalcancersasingleinstitutionretrospectiveanalysis AT dhwanipatel tas102plusbevacizumabasaneffectiveandwelltoleratedregimeninchemotherapyrefractoryadvancedcolorectalcancersasingleinstitutionretrospectiveanalysis AT atultiwari tas102plusbevacizumabasaneffectiveandwelltoleratedregimeninchemotherapyrefractoryadvancedcolorectalcancersasingleinstitutionretrospectiveanalysis AT jatinchoudhary tas102plusbevacizumabasaneffectiveandwelltoleratedregimeninchemotherapyrefractoryadvancedcolorectalcancersasingleinstitutionretrospectiveanalysis AT pranayavana tas102plusbevacizumabasaneffectiveandwelltoleratedregimeninchemotherapyrefractoryadvancedcolorectalcancersasingleinstitutionretrospectiveanalysis AT vallishshenoy tas102plusbevacizumabasaneffectiveandwelltoleratedregimeninchemotherapyrefractoryadvancedcolorectalcancersasingleinstitutionretrospectiveanalysis AT nehamer tas102plusbevacizumabasaneffectiveandwelltoleratedregimeninchemotherapyrefractoryadvancedcolorectalcancersasingleinstitutionretrospectiveanalysis AT anantramaswamy tas102plusbevacizumabasaneffectiveandwelltoleratedregimeninchemotherapyrefractoryadvancedcolorectalcancersasingleinstitutionretrospectiveanalysis AT prabhatbhargava tas102plusbevacizumabasaneffectiveandwelltoleratedregimeninchemotherapyrefractoryadvancedcolorectalcancersasingleinstitutionretrospectiveanalysis AT vikasostwal tas102plusbevacizumabasaneffectiveandwelltoleratedregimeninchemotherapyrefractoryadvancedcolorectalcancersasingleinstitutionretrospectiveanalysis |